Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD5789 (trifarotene) 50 μg/g cream vs vehicle in acne vulgaris
2016-002860-15Phase 3Completed
- Sponsor
- Galderma
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acne vulgaris comparing Trifarotene 50 μg/g cream with Vehicle cream (2 arms). Primary endpoint: Success rate (overall primary endpoint). Started Oct 2016; status: completed.
02
Drugs
trifarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2016-002860-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002860-15.